Replies to post #244617 on Biotech Values

[north40000]

JNJ not inclined, per PR earlier this week.

[DewDiligence]

AMGN acquires HZNP for $116.50/sh cash—a 48% premium to HZNP’s “unaffected” closing price on 11/29/22:

https://finance.yahoo.com/news/1-amgen-set-buy-biotech-084931579.html

The nominal deal value (including assumed debt) is $28.3B.